Reserpine and Extracellular-Fluid Volume
- 23 May 1957
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 256 (21) , 1000-1002
- https://doi.org/10.1056/nejm195705232562107
Abstract
IT is a well established observation that Rauwolfia therapy causes an increase in body weight in some hypertensive subjects. Certain clinical observations have suggested that this weight increase might be the result of fluid retention. McGregor and Segel,1 Perera,2 Smirk and McQueen3 and Marley and Pare4 have described edema, breathlessness and raised venous pressure after Rauwolfia therapy for hypertension; Marley and Pare also reported a weight increase and a fall in hematocrit in nonhypertensive subjects on reserpine. Sarwer-Foner5 and Ferguson6 have noted edema in psychiatric patients given reserpine, and Greenblatt7 found that the edema of premenstrual tension became more pronounced . . .Keywords
This publication has 11 references indexed in Scilit:
- ReserpineBMJ, 1956
- ReserpineBMJ, 1956
- Cardiac Failure with ReserpineBMJ, 1956
- CLINICAL NOTESJAMA, 1955
- COMPARISON OF RESCINNAMINE AND RESERPINE AS HYPOTENSIVE AGENTSThe Lancet, 1955
- THE RAUWOLFIA ALKALOIDS IN THE TREATMENT OF HYPERTENSIONHeart, 1955
- Rauwolfia serpentina in Hypertensive Vascular Disease.,Experimental Biology and Medicine, 1954
- THE CARDIOVASCULAR AND RENAL HEMODYNAMIC RESPONSE TO THE ADMINISTRATION OF RESERPINE (SERPASIL)The Lancet Healthy Longevity, 1954
- ENDOCRINE ASPECTS OF THE PHARMACOLOGY OF RESERPINEAnnals of the New York Academy of Sciences, 1954
- USE OF RESERPINE (SERPASIL) IN CERTAIN GYNECOLOGIC DISORDERSAnnals of the New York Academy of Sciences, 1954